APP:CC - GCAC Engages Leading Marketing Firm to Drive Sales and Awareness
(TheNewswire)
St r ategy part of broader 2022 revenue focusedinitiatives
Vancouver, British Columbia, Canada - TheNewswire - May 3, 2022 - Global Cannabis ApplicationsCorp. (“ GCAC” or the “ Company” )( C NSX :APP. CN) ( FSE:2FA ) ( OTC:FUAPF ), a leading medical cannabischain-of-custody compliance and data platform, announces that the Company has entered into 6-month marketingand consulting agreement with Toronto-based marketing firm, NorthEquities Corp. (the “ Agreement ”). North Equities Corp.(“ North Equities ”) specializes in various social media platforms and willbe able to facilitate greater awareness and widespread disseminationof the Company's news releases and corporate developments.
North Equities will provide marketing services tocommunicate to the financial and cannabis communities informationabout the Company and its products. A dedicated brand ambassador willlead this engagement and announcements onGCAC’s YouTube Channel [1], social media and other driving mediumsincluding influencer-based videos and written articles. Additionally, North Equities will postinformation about the Company and its products on North Equities ownedchannels, such as Twitter.
In connection with the Agreement, the Company will pay North Equitiesa total of CAD$100,000 and issue an aggregate of 585,000 stockoptions, each exercisable into a common share of the Company at aprice of CAD$0.05, to North Equities.
CEO Bradley Moore stated, “After posting a recordthirty plus press releases[2] in 2021 and announcing our Canadianmedical license, revenues of USD$1.5M, deal opportunities in SouthAfrica, the launch of the ESG intiative, and much much more this yearalready, GCAC has an important story to tell both to customers and theinvestment community. We believe that North Equities with their uniqueand proven social approach is the right partner to assist GCAC ingaining exposure.”
Efixii is licensed to cultivators in a SaaS model andis a free-to-use app for cannabis consumers. All cannabis sold throughthe Portal generates a new sales-commission revenue stream for GCAC.Efixii’s cannabis data is the intellectual property (“ IP ”) of GCAC. ThisIP creates an inherent difficulty in replicating or competing withGCAC’s cannabis datasets. GCAC defined their protocols in aprovisional U.S. patent application, ‘System of Process and TrackingCannabis Products and Associated Method Using Blockchain’ filed withthe USPTO on December 17, 2020.
[1]https://www.youtube.com/channel/UCZkTWxcycLUPNy0GvVcM1vQ
[2] https://newsroom.cannappscorp.com/
About Global Cannabis ApplicationsCorp. (“GCAC”)
GCAC is a global leader in designing, developing, SaaSlicensing and acquiring innovative data technologies for the medicalcannabis industry. The Citizen Green and Efixii platforms are theworld's first end-to-end - from patient to regulator - medicalcannabis data solutions. They use six core technologies: mobileapplications, artificial intelligence, RegTech, smart databases,Ethereum blockchain and GCAC smart rewards. These technologiestransparently disclose cannabis chain-of-custodyevents, enabling patients to provide crowd-sourced medical cannabisefficacy data. Driven by digital and cannabis industry experts, GCACis focused on generating revenue from SaaS licensing its technologyand acquiring high-quality cannabis datasets that improve patientoutcomes and become the world’s largest cannabis efficacy dataprovider.
For more Company information, please visit www.cannappscorp.com , or review theCompany’s profiles on www.sedar.com and on theCanadian Securities Exchange's website at www.thecse.com .
Press Contact
Phone: +1 (800) 409-5679
Email: info@cannappscorp.com
Forward-Looking Information
This news release mayinclude forward-looking information within the meaning of Canadiansecurities legislation concerning the business of GCAC.Forward-looking information is based on certain key expectations andassumptions made by the management of GCAC. Although management of theCompany believes that the expectations and assumptions on which suchforward-looking information is based are reasonable, undue relianceshould not be placed on the forward-looking information because GCACcan give no assurance that they will prove to be correct.Forward-looking statements contained in this news release are made asof the date of this news release. GCAC disclaims any intent orobligation to update publicly any forward-looking information, whetheras a result of new information, future events or results or otherwise,other than as required by applicable securities laws.
The CanadianSecurities Exchange has not reviewed and does not acceptresponsibility for the adequacy and accuracy of thisinformation.
Copyright (c) 2022 TheNewswire - All rights reserved.